Jorge Puig de la Bellacasa
Overview
Explore the profile of Jorge Puig de la Bellacasa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vergara A, Boutal H, Ceccato A, Lopez M, Cruells A, Bueno-Freire L, et al.
Microorganisms
. 2020 Jan;
8(1).
PMID: 31940771
Rapid identification of the causative agent of hospital-acquired pneumonia (HAP) will allow an earlier administration of a more appropriate antibiotic and could improve the outcome of these patients. The aim...
2.
Fernandez-Pittol M, Alejo-Cancho I, Rubio E, Lopez M, Garcia A, Mascaro J, et al.
Rev Iberoam Micol
. 2019 Mar;
36(2):90-92.
PMID: 30853370
Background: Phaeoacremonium parasiticum is considered a rare infectious agent that is part of a heterogeneous group of fungi causing phaeohyphomycosis. This organism is capable of producing subcutaneous infections, eumycetomas, osteomyelitis,...
3.
Xipell M, Losno R, Garcia-Vidal C, Rovira M, Alejo-Cancho I, Puig de la Bellacasa J, et al.
Rev Iberoam Micol
. 2018 Oct;
35(3):162-166.
PMID: 30274955
Background: The most common presentation of mucormycosis in the past was the nasosinusal involvement in patients with diabetic ketoacidosis. However, in the last few years, new groups of patients with...
4.
Cilloniz C, Ferrer M, Liapikou A, Garcia-Vidal C, Gabarrus A, Ceccato A, et al.
Eur Respir J
. 2018 Mar;
51(3).
PMID: 29545274
Our aim was to assess the incidence, characteristics, aetiology, risk factors and mortality of acute respiratory distress syndrome (ARDS) in intensive care unit (ICU) patients with community-acquired pneumonia (CAP) using...
5.
Liapikou A, Cilloniz C, Gabarrus A, Amaro R, Puig de la Bellacasa J, Mensa J, et al.
Eur Respir J
. 2016 Apr;
48(1):257-61.
PMID: 27103390
No abstract available.
6.
Cilloniz C, Gabarrus A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, et al.
Chest
. 2016 Apr;
150(2):415-25.
PMID: 27060725
Background: Pseudomonas aeruginosa is not a frequent pathogen in community-acquired pneumonia (CAP). However, in patients with severe CAP, P aeruginosa can be the etiology in 1.8% to 8.3% of patients,...
7.
Prina E, Ranzani O, Polverino E, Cilloniz C, Ferrer M, Fernandez L, et al.
Ann Am Thorac Soc
. 2014 Dec;
12(2):153-60.
PMID: 25521229
Rationale: To identify pathogens that require different treatments in community-acquired pneumonia (CAP), we propose an acronym, "PES" (Pseudomonas aeruginosa, Enterobacteriaceae extended-spectrum β-lactamase-positive, and methicillin-resistant Staphylococcus aureus). Objectives: To compare the...
8.
Gago S, Esteban C, Valero C, Zaragoza O, Puig de la Bellacasa J, Buitrago M
J Clin Microbiol
. 2014 Jan;
52(4):1168-76.
PMID: 24478409
A molecular diagnostic technique based on real-time PCR was developed for the simultaneous detection of three of the most frequent causative agents of fungal opportunistic pneumonia in AIDS patients: Pneumocystis...
9.
Rey-Jurado E, Tudo G, Puig de la Bellacasa J, Espasa M, Gonzalez-Martin J
Int J Antimicrob Agents
. 2013 Jan;
41(3):278-80.
PMID: 23312604
Multidrug resistance has become a problem in the management of tuberculosis, leading to an urgent need for research related to new regimens including the currently available drugs. The objectives of...
10.
Vila J, Juiz P, Salas C, Almela M, Garcia de la Fuente C, Zboromyrska Y, et al.
J Clin Microbiol
. 2012 Feb;
50(5):1745-7.
PMID: 22337985
The identification of 83 Corynebacterium, 13 Arcanobacterium haemolyticum, and 10 Rhodococcus equi strains by conventional methods (API Coryne complemented with 16S rRNA gene sequence analysis) was compared with matrix-assisted laser...